Sorbinil Retinopathy Trial (SRT)
NCT00000159 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the safety and efficacy of the investigational drug sorbinil, an aldose reductase inhibitor, in preventing the development of diabetic retinopathy and neuropathy in persons with insulin-dependent diabetes.
Conditions
Interventions
- DRUG
-
Sorbinil
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 56 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1983-08-31
More Related Trials
-
A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy
NCT07198815 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Sirolimus to Treat Diabetic Macular Edema
NCT00711490 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diabetic Retinopathy Sulodexide Study
NCT01295775 ·Status: COMPLETED ·Phase: PHASE2
-
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
NCT00131144 ·Status: COMPLETED ·Phase: PHASE3
-
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
NCT00130845 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Diabetes Mellitus Patients With Retinopathy
NCT00828425 ·Status: COMPLETED
-
Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
NCT05383209 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Diabetic Retinopathy Study (DRS)
NCT00000160 ·Status: COMPLETED ·Phase: PHASE3
-
Diabetic Retinopathy Candesartan Trials
NCT00252733 ·Status: COMPLETED ·Phase: PHASE3
-
A New Treatment of Retinitis Pigmentosa
NCT03998384 ·Status: UNKNOWN ·Phase: NA
-
REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus
NCT04025996 ·Status: UNKNOWN
-
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
NCT00406991 ·Status: COMPLETED ·Phase: PHASE2
-
Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
NCT00411333 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
NCT00248131 ·Status: TERMINATED ·Phase: PHASE3
-
Reduction in the Occurrence of Center-Involved Diabetic Macular Edema
NCT00090519 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
NCT03112005 ·Status: COMPLETED
-
Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
NCT00915837 ·Status: COMPLETED ·Phase: PHASE1
-
Automated AI-based System for Early Diagnosis of Diabetic Retinopathy
NCT05324189 ·Status: UNKNOWN
-
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
NCT02099981 ·Status: COMPLETED ·Phase: PHASE1
-
Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients
NCT05608265 ·Status: COMPLETED ·Phase: NA
-
Specular Microscopy in Patients With Proliferative Diabetic Retinopathy
NCT05838898 ·Status: UNKNOWN
-
Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema
NCT00994955 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Laser and Medical Treatment of Diabetic Macular Edema
NCT00050479 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
NCT04292912 ·Status: TERMINATED ·Phase: PHASE1